NFKB1 and neoplasm: Reduced T cell-NF-κB activity did not reduce expansion of tumor-specific T cells, but resulted in decreased production of tumor antigen-specific IFN-γ and TNF-α, as well as diminished cytotoxicity against tumor antigen-expressing cells in vivo.